Table 3.
Antibody* | Function† | Specificity in Vasculature† | Fibroblastic Cells | Myofibroblastic Cells | C‐SMCs | |
---|---|---|---|---|---|---|
Mesenchymal lineage | 1. Vimentin 12 , 13 , 14 | Stabilization of cytoskeletal interactions and maintenance of cell shape and integrity of the cytoplasm 48 , 49 | Expressed in leukocytes and endothelial cells as well 50 , 51 | |||
2. S100A4/FSP‐1 15 , 16 , 17 | Involved in proteolytic activity during ECM remodeling and cell migration, proliferation, differentiation, and contractility 52 , 53 , 54 | Expressed in leukocytes as well 52 , 54 , 55 | ||||
3. CD90/Thy‐1 15 , 18 , 19 | Involved in cell adhesion and cell communication 56 | Expressed in endothelial cells as well 57 | ||||
4. FAP 20 , 21 , 22 | Thought to promote cellular invasion through the ECM 58 | Expressed in leukocytes as well 59 | ||||
Contractile apparatus | 5. αSMA 23 , 24 , 25 | Force generation 60 , 61 , 62 | Expressed in macrophage‐like phenotype (foam cells) as well 63 , 64 | |||
6. Smemb 25 , 26 , 27 | Thought to be involved in diverse processes, including cytokinesis, cell shape, and secretion 65 | Restricted to mesenchymal cells 66 | ||||
7. SM‐MHC 28 , 29 , 30 | Force generation 17 , 67 | Restricted to mesenchymal cells 68 | ||||
Accessory contractile | 8. h1‐Calponin 28 , 31 , 32 | Regulation and modulation of smooth muscle contraction 69 | Restricted to mesenchymal cells 70 | |||
9. h‐Caldesmon 13 , 33 , 34 | Regulation of smooth muscle contraction 71 | Restricted to mesenchymal cells 72 | ||||
10. Desmin 13 , 34 , 35 | Maintenance of myofibril, myofiber, and whole muscle tissue structural and functional integrity 73 , 74 | Restricted to mesenchymal cells (in vasculature) 75 | ||||
11. SM22α 22 , 28 , 29 | Involved in the reorganization of the actin cytoskeleton and cell contractility 76 , 77 | Restricted to mesenchymal cells 78 | ||||
12. Smoothelin‐B 28 , 36 , 37 | Associates with stress fibers and constitutes part of the cytoskeleton 79 | Restricted to mesenchymal cells 80 | ||||
13. a‐Tropomyosin 27 , 38 , 39 | Regulation of smooth muscle contraction 81 | Restricted to mesenchymal cells 82 | ||||
14. Telokin 40 , 41 , 42 | Involved in initiation or maintenance of smooth muscle relaxation as well as in contraction 83 , 84 | Restricted to mesenchymal cells 85 | ||||
Focal adhesion | 15. Paxillin 43 , 44 , 45 | Focal adhesion protein involved in cell‐matrix adhesion and presumably coordination of transmission of downstream signals in cell movement and migration 86 | Expressed in leukocytes, endothelial cells, and epithelial cells as well 87 | |||
16. Vinculin 38 , 46 , 47 | F‐actin binding protein involved in cell‐matrix adhesion and cell‐cell interactions 88 | Expressed in leukocytes, endothelial cells, and epithelial cells as well 89 |
The selected phenotypical markers are divided in 3 main groups, of which the contractile markers are subdivided on the basis of whether they are part of the contractile apparatus or they are accessory proteins that regulate actin‐myosin interaction. Fibroblastic cells, myofibroblastic cells, and C‐SMCs were evaluated on their reported discriminative power: dark gray represents controversy over discriminating ability of the marker, and light gray represents consensus that the marker is nondiscriminative. CD indicates cluster of differentiation; C‐SMC, contractile smooth muscle cell; ECM, extracellular membrane; FAP, fibroblast activation protein; FSP‐1, fibroblast‐specific protein‐1; αSMA, α‐smooth muscle actin; SM22α, smooth muscle protein 22α; Smemb, nonmuscle myosin heavy chain; SM‐MHC, smooth muscle myosin heavy chain; and Thy‐1, thymocyte differentiation antigen 1.
References from systematic review.
Supplementary references (not from systematic review).